| Product NDC: | 0002-8400 |
| Proprietary Name: | Forteo |
| Non Proprietary Name: | Teriparatide |
| Active Ingredient(s): | 250 ug/mL & nbsp; Teriparatide |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0002-8400 |
| Labeler Name: | Eli Lilly and Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021318 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20081001 |
| Package NDC: | 0002-8400-99 |
| Package Description: | 1 SYRINGE in 1 CARTON (0002-8400-99) > 2.4 mL in 1 SYRINGE |
| NDC Code | 0002-8400-99 |
| Proprietary Name | Forteo |
| Package Description | 1 SYRINGE in 1 CARTON (0002-8400-99) > 2.4 mL in 1 SYRINGE |
| Product NDC | 0002-8400 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Teriparatide |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20081001 |
| Marketing Category Name | NDA |
| Labeler Name | Eli Lilly and Company |
| Substance Name | TERIPARATIDE |
| Strength Number | 250 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Parathyroid Hormone [Chemical/Ingredient],Parathyroid Hormone Analog [EPC] |